Myeloproliferative Neoplasm Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-16
Nov 16, 2021
H
Recruiting
  • Myeloproliferative Neoplasm
  • Fedratinib Pill
  • Tampa, Florida
    Moffitt Cancer Center
2021-11-09
Nov 9, 2021
P
Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
2021-11-17
Nov 17, 2021
U
Not yet recruiting
  • Myeloproliferative Neoplasm
  • +4 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
2021-11-05
Nov 5, 2021
R
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2021-11-16
Nov 16, 2021
M
Not yet recruiting
  • Acute Leukemia
  • +3 more
  • VIC- 1911
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
2021-11-03
Nov 3, 2021
F
Recruiting
  • Myeloproliferative Neoplasm
  • COVID
    • New York, New York
    • +40 more
    2021-11-11
    Nov 11, 2021
    U
    Active, not recruiting
    • Acute Biphenotypic Leukemia
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2021-11-10
    Nov 10, 2021
    M
    Recruiting
    • Acute Lymphoblastic Leukemia
    • +12 more
    • Anti-Thymocyte Globulin
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-11-09
    Nov 9, 2021
    U
    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Online Mindfulness Meditation
    • Internet-Based Webinars
    • San Francisco, California
      University of California San Francisco
    2021-11-08
    Nov 8, 2021
    O
    Recruiting
    • Myeloproliferative Neoplasm
    • +5 more
    • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
    • Aspirin 81 mg
    • Ottawa, Ontario, Canada
      The Ottawa Hospital
    2021-10-28
    Oct 28, 2021
    C
    Recruiting
    • Carcinoma In Situ
    • +10 more
    • Cytology Specimen Collection Procedure
    • Medical Chart Review
    • Birmingham, Alabama
    • +236 more
    2021-10-15
    Oct 15, 2021
    N
    Suspended
    • Acute Myeloid Leukemia
    • +5 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center LAO
    2021-10-14
    Oct 14, 2021
    U
    Not yet recruiting
    • Myeloproliferative Neoplasm
    • BCR-ABL Negative
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    2021-09-29
    Sep 29, 2021
    T
    Not yet recruiting
    • Leukemia
    • +4 more
    • CHAMPS-II adapted to adults 60+ years in HCT setting
    • Survivorship education active control
    • Omaha, Nebraska
      University of Nebraska Medical Center
    2021-09-28
    Sep 28, 2021
    M
    Recruiting
    • Acute Leukemia
    • +7 more
    • Biospecimen Collection
    • Electronic Health Record Review
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    2021-09-13
    Sep 13, 2021
    R
    Active, not recruiting
    • Myeloproliferative Neoplasm
    • +3 more
    • standard of care.
    • (no location specified)
    2021-09-14
    Sep 14, 2021
    H
    Active, not recruiting
    • Myelodysplastic Syndrome
    • +3 more
    • Tampa, Florida
    • +5 more
    2021-09-14
    Sep 14, 2021
    U
    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    2021-08-27
    Aug 27, 2021
    S
    Recruiting
    • Acute Myeloid Leukemia
    • +14 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    2021-08-31
    Aug 31, 2021
    A
    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Birmingham, Alabama
    • +9 more
    2021-08-30
    Aug 30, 2021